APTAMERS FOR INTRAOPERATIVE STAINING OF BRAIN GLIOBLASTOMA

HIGH SPECIFICITY

FOR YOUR RESULTS

OUR MISSION

We develop tools for diagnostics and treatment of socially significant diseases based on DNA-Aptamers.

We make them effective and affordable.


Aptamers for intraoperative staining of brain glioblastoma

Objective: to obtain DNA aptamers capable of specifically contrasting the boundaries of brain glioblastoma in vivo

Aptamers were selected from a DNA library of oligonucleotides using the Cell SELEX method to postoperative glioblastoma tissues. Tissues of benign brain tumors and conventionally healthy brain tissues adjacent to tumor ones were used as negative targets.
The obtained aptamers specifically bound to the primary tumor of glioblastoma and did not stain healthy brain cells (Patent RU 2 654 665 C2). The putative targets of the obtained aptamers were glial fibrillary acidic protein (GFAP), tubulin alpha-1C chain (TUBA1C) and myelin basic protein (MBP) acidic protein with post-translational modifications and pancreatic lipase-related protein 3. The 3D structure of the Gli-233 aptamer was determined using small-angle scattering and computer simulation methods. Aptamers conjugated with a fluorescent Brilliant Violet 650 dye (Gli-233BV) did not show in vivo toxicity in preclinical animal studies and were used for tumor visualization during fluorescence-guided surgery in patients. The anti-GBM aptamer was conjugated with a fluorescent Brilliant Violet 650 dye (Gli-233BV) and applied on tissues during the surgical removal.

Find out how we will solve your TASK

CRM-форма появится здесь
We use cookies
Cookie preferences
Below you may find information about the purposes for which we and our partners use cookies and process data. You can exercise your preferences for processing, and/or see details on our partners' websites.
Analytical cookies Disable all
Functional cookies
Other cookies
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. Learn more about our cookie policy.
Details I understand
Cookies